Sam SS, Gayón VE

Language: Spanish
References: 14
Page: 151-156
PDF size: 286.43 Kb.

ABSTRACT

Some types of human papiloma virus (HPV) can cause cervical cancer of the uterus. One of the most worrisome observations is the high prevalence and frequency of high-grade risk virus serotypes in teenagers. This may be due to the high vulnerability of the female genital tract during this period. The prevalence of HPV in adolescent females is between 16 and 20%; the exofitic condilomas (genital warts) are frequently located at the vulvar and anal regions. New treatment options are highly effective in this population. At the present time there is a tendency to favor a conservative management of cervical lesions caused by HPV in adolescents; however, immunodeficient patients require close surveillance. It is recommended that teenage females have their first gynecological check up at 13 years of age, with special emphasis on prevention. The medical professionals who work with teenagers should apply the recommendations suggested in this paper, on daily basis. The development of specific vaccines will greatly reduce the frequency of cervical cancer and pre-cancer lesions in this high-risk group.

REFERENCES

1. Kristin M, Jessica A. Human Papillomavirus and Adolescent0 Girls. Current Women´s Health 2002;(2):468-75.

2. Emans S, Laufer M, Goldstein D. Pediatric and Adolecent 1Gnecology. Cuarta Edición, McGraw-Hill Interamericana 2002;pp388-406.

3. Perlman S, Nakajima S, Hertweek S. Clinical Protocols in Pediatric and Adolescent gynecology. Parthenon Publising 2004;pp36-39.

4. Edwards L. Imiquimod in clinical practice. J Am Acad Dermatol 2000;43:S12–S17.

5. Alan M. Direct medical cost for surgical and medical treatment of condylomata accuminata. Arch Dermatol 2001;137:337-41.

6. Szarewski A, Sasieni P. Cervical screening in adolescents at least do no harm. Lancet 2004;354:1678-83.

7. Guido R. Guidelines for screening and treatment of cervical disease in the adolescent. J Pediatr Adolescent Gynecol 2004; 17:303-311.

8. Solomon D, Davey D, Kurman R. The 2001 Bethesda System terminology for report results of cervical cytolgy. JAMA 2002;287:2114-9.

9. Schiffman M, Adrianza M. ASCUS-LSIL triage study: design, methods, and characteristics of trial participants. Acta Cytol 2000;44:726-42.

10. Solomon D, Schiffman M, Tarone R. ASCUS/LSIL triage study (ATLS): conclusions reaffirmed: response to a November 2001 Commentary. Obstet Gynecol 2002;(99):671-674.

11. Center for Disease Control and Prevention. Sexually transmitted diseases treatment Guidelines MMWR 2002;51(No. RR6).

12. Bacon J, Farnacoeur D, Goldfarb A, Breech L. Abnormal pap smears in adolescents. J Pediatr Adolesc Gynecol 2003;16:157-66.

13. Dell D, Chen H, Ahmad F, Stewart D. Knowledge about human papillomavirus among adolescents. Obstet Gynecol 2000;96:653-6.

14. Lazcano Ponce E, Rivera L, Arillo-Santillan E, Salmeron J, Hernández Avila M, Muñoz N. Acceptability of a human papillomavirus (HPV) trial vaccine among mothers of adolescents in Cuernavaca México. Arch Med Res 2001;32:243-7.